RL
MindMaze Therapeutics Holding S.A.
RLFTY · OTC
$0.42 +0.00% (+$0.00)
Market Cap CHF 53.9M
P/E Ratio -
Div. Yield -
ROE 25.25%
Piotroski F-Score Weak
2/9Valuation
50 /100
Fair P/S 83.90x
P/B 1.40x
P/E N/A
Growth
0 /100
Declining Rev. growth 52.74%
Book val. growth 35.88%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 92.06%
FCF margin 1,126.17%
Net margin 1,542.99%
Quality
0 /100
Poor ROIC 25.50%
Asset turnover 0.01x
ROE 25.25%
Debt
58 /100
Moderate Debt/Equity 0.05x
Int. coverage -36.24x
Current ratio 1.20x
Stability
1 /100
Unstable Beta 2.84x
Profitable years 0
Rev. volatility 67.59%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RLFTY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Zach W. Henderson
Employees
10
Headquarters
Geneva